Drug Controller General of India

Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…

The DGCI, Dr V G Somani, called for more investment in R&D during an IPA convention in New Delhi which was attended by over…

He will be be India's first full time DCGI in nearly two years after Dr G N Singh left the position in early 2018